-
The Asia-Pacific session unfolded in a calm and optimistic mood. Chinese indices are gaining between 0.80–1.10%, SG20cash is down 0.08%, AU200.cash is up 0.10%, and Japan’s JP225 is down 0.25%.
-
Today we will receive the delayed U.S. PCE report for September.
-
In October, household spending in Japan fell –3.0% y/y and –3.5% m/m, significantly below forecasts, signaling fragile demand and complicating the BOJ’s December policy debate.
-
Despite this, the BOJ is leaning toward a 25 bp hike in December. Internal discussions suggest policymakers prefer raising rates to 0.75% next month and are open to further gradual tightening.
-
The WSJ reports that Masayoshi Son is exploring a multi-billion-dollar AI industrial-parks project on U.S. federal land, tied to the new U.S.–Japan trade framework.
-
Gold held above 4,200 USD per ounce, gaining 0.42% today. Oil, on the other hand, is down 0.27% to 59.50 USD per barrel.
-
Netflix is reportedly in exclusive talks to acquire Warner Bros Discovery studio. According to reports, Netflix is negotiating a purchase at 28 USD per share with an exclusivity clause.
-
India’s central bank, the RBI, is cutting rates by 25 bp to 5.25% in a unanimous decision. Despite pressure on the Indian rupee, resilient growth and recent disinflation allowed for easing. Governor Malhotra described the current environment as a “rare golden period.”
-
Moore Threads surged 400% on debut in Shanghai as part of China’s GPU offensive. Shares of the “Chinese Nvidia” exploded after a 1.1 billion USD IPO, showcasing intense capital support for domestic GPU manufacturers amid U.S. export controls on Nvidia.
Economic calendar: US UoM data in the spotlight (24.04.2026)
BREAKING: US PMIs beat estimates 📈 Stocks back in the green
💶European PMI Plunges as Iran Conflict Batters Economic Activity
Economic Calendar: PMI in Focus, a Key Day for Global Markets
The material on this page does not constitute as financial advice and does not take into account your level of understanding, investment objectives, financial situation or any other particular needs.
All the information provided, including opinions, market research, mathematical results and technical analyses published on the website or transmitted to you by other means is provided for information purposes only and should in no event be interpreted as an offer of, or solicitation for, a transaction in any financial instrument, nor should the information provided be construed as advice of legal or fiscal nature.
Any investment decisions you make shall be based exclusively on your level of understanding, investment objectives, financial situation or any other particular needs. Any decision to act on information published on the website or transmitted to you by other means is entirely at your own risk. You are solely responsible for such decisions.
If you are in doubt or are not sure that you understand a particular product, instrument, service, or transaction, you should seek professional or legal advice before trading.
Investing in OTC Derivatives carries a high degree of risk, as they are leveraged based products and often small movements in the market could lead to much larger movements in the value of your investment and this could work against you or for you. Please ensure that you fully understand the risks involved, taking into account your investments objectives and level of experience, before trading, and if necessary, seek independent advice.
